SENP3 level showed a negative correlation (R < −0.6) with CD206 level in patients with advanced tumors (stage T3/T4, TNM grade III, and lymph node metastasis), whereas such a correlation was not seen in lower‐grade tumors (Table 4). This evidence concerns the gene SENP3 and metastatic malignant neoplasm in the lymph nodes.